Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NHI Price Ceiling to Be Set: Reform Proposal -2-
October 22, 2001
- 60th Annual Meeting of the Japanese Cancer Association
October 22, 2001
- MOF Proposes 30% Copayment Rate for All Patients
October 22, 2001
- COPD Prevalence Reaches 8.5% in Japanese over 40: Dr Fukuchi
October 22, 2001
- Drug Companies Need to Enhance Int'l Competitiveness: JPA Congress
October 22, 2001
- South Africa Invites Japanese Firms to Come to Conduct Clinical Trials
October 22, 2001
- Market Economy to Turn Healthcare into Darwinian Jungle: Dr Itouji of JMA
October 22, 2001
- RESEARCH & DEVELPMENT NEWS IN BRIEF
October 22, 2001
- Korosho Proposes to Raise Monthly Upper Limit of Copayments
October 22, 2001
- WORLD NEWS IN BRIEF
October 22, 2001
- 10 New Themes for Basic Research Promotion Selected
October 22, 2001
- NEW PRODUCTS NEWS IN BRIEF
October 22, 2001
- Instrumentarium Imaging to Launch New X-ray Mammograph
October 15, 2001
- Mitsubishi Pharma Revises Business Forecasts Upward
October 15, 2001
- Fujisawa Revises Business Forecasts Upward
October 15, 2001
- Laerdal Medical to Launch Patient Simulator SimMan
October 15, 2001
- BUSINESS NEWS IN BRIEF -2-
October 15, 2001
- Aiming at \300 Bil. Sales in FY2006: Mr Nagasaka of Banyu
October 15, 2001
- Taiho: Sales Up 3.9% to \96.4 Bil.
October 15, 2001
- Ribavirin, INF Combination Recommended for Approval for Hepatitis C
October 15, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…